Navigation Links
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
Date:11/1/2011

TUESDAY, Nov. 1 (HealthDay News) -- Age in itself should not be a factor in deciding whether blood cancer patients are candidates for stem cell transplantation, according to a new study.

Blood cancers include leukemia, lymphoma and myeloma.

For the study, researchers analyzed long-term outcomes among 372 blood cancer patients aged 60 to 75 who underwent a "mini-transplant," which is a "kinder, gentler" form of allogeneic (cells from another person) stem cell transplantation developed at the Fred Hutchinson Cancer Research Center in Seattle.

The five-year rates of overall survival and disease progression-free survival among the patients were 35 percent and 32 percent, respectively. Comparable survival rates were seen when the patients were divided into three age groups -- 60 to 64, 65 to 69, and 70 to 75 -- suggesting that age plays a limited role in the success of the mini-transplant.

While a survival rate of one-third may seem low, all of the patients would have died within months if they didn't have the transplant, Dr. Mohamed Sorror, an assistant member of the Hutchinson Center's Clinical Research Division, noted in a news release from the Center.

The investigators also found that greater cancer aggressiveness and having a larger number of medical problems not linked to cancer ("comorbidities") were two factors that affected survival, regardless of age.

For example, the five-year survival for patients with less aggressive cancer and fewer comorbidities was 69 percent, compared with 23 percent for patients with more aggressive cancer and a large number of comorbidities, according to the report in the Nov. 2 issue of the Journal of the American Medical Association.

Conventional stem cell transplants are generally not performed on blood cancer patients older than 60 because high doses of total-body radiation and potent chemotherapy are used to prepare patients for transplantation.

However, the mini-transplant relies on the donor's immune cells to kill the cancer, and low-dose radiation and chemotherapy is used to suppress the immune system rather than destroy it.

More information

The U.S. Centers for Disease Control and Prevention has more about blood cancers.

-- Robert Preidt

SOURCE: Fred Hutchinson Cancer Research Center, news release, Nov. 1, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dementia Rates Escalate as Brain Capacity Diminishes with Age
2. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
3. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
4. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
5. Rate Regulation for Health Insurance: Obama Administration Should Look to CAs Model Law Which Has Saved Drivers $62 Billion Since 1988
6. CareTech Solutions Showcases Web Portal for Hospital Boards and Administrators at HIMSS10
7. National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics
8. Adverse events rate is low when propofol is administered by trained professional
9. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
10. New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid
11. The Power of Prayer Deterred Tsunami's Destruction Ministry Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, ... teaching their patients about the key role this treatment plays in protecting oral health, ... endodontist. To better serve those who need a root canal in White Plains, NY ...
(Date:3/27/2017)... ... March 27, 2017 , ... SyncDog, Inc. , the ... partners LG Business Solutions at ATARC Federal Mobile Computing Summit , March ... provide education and examination into the mobility tools and technology employed by the ...
(Date:3/27/2017)... ... ... The Case Management Society of America (CMSA) will install six new members ... has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on the ... position has also been added to the BOD, per an appointment made by CMSA ...
(Date:3/27/2017)... ... March 27, 2017 , ... Advantexe ... announced the launch of a new research study, The Business Readiness Report. The ... execute that strategy, and the actual success of achieving individual and company goals. ...
(Date:3/27/2017)... ... ... is still in shock after receiving a $2,500 Academic Award from California Casualty . ... , She thinks the coming week is going to be a very joyful for her ... my students.” , The award will allow the 4th grade teacher at Tumwater Hill Elementary ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  Twist Bioscience, a company accelerating science ... that it raised an additional $33 million. To date, ... "It is an exciting time to ... and continue to deliver industry-leading gene volume to our ... Emily M. Leproust, Ph.D., CEO of Twist Bioscience. "We ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/27/2017)... , March 27, 2017 Invivotek, LLC, a ... in vivo pharmacology contract research organization (CRO), ... to its newly expanded preclinical research facility in ... provides a cleaner, renewable energy source to reduce costs ... Completion of the Genesis Solar Farm follows Invivotek,s recent ...
Breaking Medicine Technology: